Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-19-040629

President and CEO acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2019-08-15 Option exercise +75,000 $3.45 $258,750 641,188 D
Derivatives
Chan Phillip P. President and CEO 2019-08-15 Option exercise · Stock Option (right to buy) −75,000 14,100 D
Loading xslF345X03/tv527919_4.xml…